Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada
- PMID: 37696554
- PMCID: PMC10495179
- DOI: 10.1503/cmaj.221051
Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is an ambulatory care-sensitive condition, and the rate of hospital admissions for COPD is an indicator of the quality of outpatient care. We sought to determine long-term trends in hospital admissions for COPD in Canada.
Methods: Using a comprehensive national database of hospital admissions in Canada, we identified those with a main discharge diagnosis of COPD for patients aged 40 years and older between 2002 and 2017. We calculated sex-specific, age-standardized trends in annual rates of hospital admissions for COPD separately for younger (40-64 yr) and older adults (≥ 65 yr). We used spline regression to examine changes in the admissions trends for each sex and age group.
Results: Over 16 years, 1 134 359 hospital admissions were for COPD. Between 2002 and 2017, the total number of admissions increased by 68.8%, from 52 937 to 89 384. The overall crude admission rate increased by 30.0%, from 368 to 479 per 100 000 population, and the sex-and age-standardized admission rate increased by 9.6%, from 437 to 479 per 100 000 population. Age-standardized rates increased by 12.2% among younger females, by 24.4% among younger males and by 29.8% among older females, but decreased by 9.0% among older males. Over the same period, the all-cause sex-and age-standardized admission rate declined by 23.0%.
Interpretation: Hospital admissions for COPD have increased since 2010, even after adjusting for population growth and aging, and despite declining rates of all-cause hospital admissions. The secular increase in COPD admissions indicates that the burden of COPD on Canadian health care systems is increasing.
© 2023 CMA Impact Inc. or its licensors.
Conflict of interest statement
Competing interests: Don Sin reports honoraria from GSK, Boehringer Ingelheim and AstraZeneca. No other competing interests were declared.
Figures
Comment in
-
How can Canada's health systems improve care for people with chronic obstructive pulmonary disease?CMAJ. 2023 Sep 11;195(35):E1182-E1183. doi: 10.1503/cmaj.230998. CMAJ. 2023. PMID: 37696560 Free PMC article. No abstract available.
References
-
- López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology 2016;21:14–23. - PubMed
-
- Khakban A, Sin DD, FitzGerald JM, et al. The projected epidemic of chronic obstructive pulmonary disease hospitalizations over the next 15 years. A population-based perspective. Am J Respir Crit Care Med 2017;195:287–91. - PubMed
-
- Health spending. Ottawa: Canada Institute of Health Information. Available: https://www.cihi.ca/en/health-spending (accessed 2022 Mar. 18).
MeSH terms
LinkOut - more resources
Full Text Sources
Medical